The APGI (Association de Pharmacie Galénique Industrielle) is organizing for the first time a workshop dedicated to Oral Controlled Release Solid Dosage forms. This includes matrix systems as well as coated dosage forms, such as tablets, pellets and capsules.
During the one day event, oral and poster presentations from academia and industry as well as practical demonstrations (in small groups) are foreseen.
The entire spectrum, ranging from engineering aspects during the manufacturing process, the portfolio of commercially available excipients allowing to formulate a large variety of drugs, the underlying mass transport mechanisms and physical principles, characterization methods for the key properties of the devices as well as potential pitfalls and hurdles to be overcome during product development will be addressed.
July 5, 2017
There are many aspects to developing medication for orphan indications. But how and when do you take the all-decisive steps that lead to success?
Come and join us during a 2-day bootcamp in Leuven, Belgium, where you will find answers to your questions, and an update on breaking innovations in orphan diseases from frontline speakers.
May 24, 2017
Are you a (post)doctoral researcher thinking about your next career move?
How about combining Industrial and Academic research?
We currently have development projects in oncology, women´s health and gastrointestinal diseases.
May 16, 2017
Avivia launches a new service division - fully dedicated to pharmaceutical excipient characterization
Excipients can have an important impact on the performance of a pharmaceutical formulation, including its stability, bioavailability and release profile. It’s therefore critical to have a complete and detailed characterization of all the excipients used in a finished dosage formulation in order to achieve a robust, stable and reproducible product.
Excipia has built a unique set of databases and complementary methods covering more than 400 pharmaceutical excipients.
March 2, 2017
The collaboration will combine EmulTech’s innovative technology with Avivia’s expertise in complex drug reformulation to deliver solutions for today’s increasing request from pharmaceutical companies. Both companies encounter customers with complex product ideas who are hitting a wall. Whether it being a new product or reformulation product, life cycle management or generics plus. Teaming up with EmulTech was a natural step as Avivia was looking to strengthen its offering to its customer and EmulTech was looking to do the same.
January 31, 2017
Avivia headquarters & lab facilities
M-building – Novio Tech Campus
6534 AT Nijmegen, The Netherlands
Phone +31 (0)6 1968 6732